🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a proof-of-concept study to determine if PH-797804 reduces neuropat...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-04
Trial ID
NCT00614705
There is no difference in the rate and extent of absorption of the material...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-11
Trial ID
NCT01226693
Treatments Being Tested
PH-797804 is an oral ant-inflammatory drug that may reduce the inflammation...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-05
Trial ID
NCT01321463
The purpose of this study is to investigate the effect of PH-797804 followi...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2013-04
Trial ID
NCT01862887
Treatments Being Tested
PH-797804 is a potent inhibitor of inflammatory mediators that have a poten...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2010-05
Trial ID
NCT01102660
Treatments Being Tested
PH-797804 is a potent ant-inflammatory drug that may reduce the inflammatio...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-02
Trial ID
NCT00559910
Initial studies have used a powder in capsule formulation of PH797804. In f...
Status
Withdrawn
Location
Multiple Locations
Start Date
2009-02
Trial ID
NCT00827515
The hypothesis of this study is that the p38 inhibitor (PH-797804) will be ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2008-03
Trial ID
NCT00620685
The purpose of this study is to investigate the effects of varying particle...
Status
Withdrawn
Location
Multiple Locations
Start Date
2014-03
Trial ID
NCT01924650
A single dose study with the inhaled anti-inflammatory agent PF-03715455 to...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-01
Trial ID
NCT01314885
Treatments Being Tested